Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimally Invasive or Conventional Edge-To-Edge Repair for Severe Mitral Regurgitation Due to Bileaflet Prolapse in Barlow's Disease: Does the Surgical Approach Have an Impact on the Long-term Results?

NCT04002648 is registered in ClinicalTrials.gov with Ospedale San Raffaele as lead sponsor.

NCT NCT04002648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04002648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimally Invasive or Conventional Edge-To-Edge Repair for Severe Mitral Regurgitation Due to Bileaflet Prolapse in Barlow's Disease: Does the Surgical Approach Have an Impact on the Long-term Results?
Lead sponsor
Ospedale San Raffaele
Phase
Observational
Overall status
Completed
Start date
December 1, 2016
Completion date
December 1, 2016
Enrollment
208 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

barlow's disease, prolapse; mitral